Education, International, EUGLOH, Research
SPOC MIRACIP : Management of immunorelated complication of cancer immunotherapy - Spring 2026
… SPOC MIRACIP : Management of immunorelated complication of cancer immunotherapy - Spring 2026 SPOC MIRACIP : Management of immunorelated complication … are the most promising drugs, they are associated with side effects in around 70% of treated patients, such called …
Published on: